drugset / Trial / NCT02678585

Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia

NCT02678585

Completed 106 enrolled Assiut University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The effect of addition of nalbuphine to lidocaine in intravenous regional anesthesia

Timeline

Start
2015-12
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nalbuphine Small molecule Intravenous
Background Lidocaine Other / unclassified Intravenous

Indications

No indication recorded.